Publication | Closed Access

Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: A preclinical study

OncologyMedicinePreclinical StudyImmunologyLung Cancer GrowthCell DeathImmune Checkpoint InhibitorTumor SuppressorCancer TreatmentP53 PathwayCancer BiologyCell BiologyCancer ResearchTumor MicroenvironmentTumor BiologyCancer Growth